Communication gaps between patients with breast cancer, caregivers, oncology care team
the ONA take:
Survey results presented at the 37th Annual San Antonio Breast Cancer Symposium reveal that discussions on basic disease information between patients with metastatic breast cancer, their caregivers, and oncologists need improvement.
The “Make your dialogue count” survey was conducted from June 2014 through August 2014. It was developed to gain insight from adult women ages 21 years and older with metastatic breast cancer, adult caregivers of these patients who attend at least half the patients’ clinic visits, and medical oncologists who treat five or more women with metastatic breast cancer per month.
Survey results indicate most patients (83%) and caregivers (76%) are extremely or very involved in treatment decisions; however, many patients and caregivers did not know the HER2 status (20% and 29%, respectively) or the HR status (16% and 30%, respectively).
In addition, 27% of oncologists indicated that they do not discuss the fact that metastatic breast cancer is incurable with patients in certain circumstances.
Most patients (73%) want more information on preventing and minimizing side effects; however, 43% of patients do not always openly discuss side effects with their oncologists. The investigators conclude that improved dialogue can clarify patients’ and caregivers’ expectations about disease management.
Discussions on basic disease information between patients with metastatic breast cancer, caregivers, and oncologists.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|